GN Store Nord A/S GGNDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $24.90
- Day Range
- $25.56–25.56
- 52-Week Range
- $16.21–27.39
- Bid/Ask
- $24.39 / $29.13
- Market Cap
- $3.72 Bil
- Volume/Avg
- 261 / 623
Key Statistics
- Price/Earnings (Normalized)
- 30.64
- Price/Sales
- 1.35
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
GN Store Nord is a Danish company offering medical and audio solutions. The group consists of two businesses: audio (about 62% of sales) and hearing (38%). GN Hearing offers hearing aids, competing globally with Sonova, Demant, Starkey, and WS Audiology (previously Sivantos and Widex). GN Audio provides headsets and speakerphones to the enterprise market (contact centers and offices), as well as to the consumer market, and recently acquired SteelSeries in the gaming market. The company has positioned itself as one of the main players in the Unified Communication-enabled headsets market. The firm’s premium brands are Resound in hearing and Jabra in headsets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,349
- Website
- https://www.gn.com
Competitors
Valuation
|
Metric
|
GGNDF
|
PHIA
|
SOON
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.64 | 15.83 | 21.56 |
Price/Book Value | 2.61 | 1.48 | 7.26 |
Price/Sales | 1.35 | 1.03 | 4.22 |
Price/Cash Flow | 11.13 | 21.59 | 19.94 |
Price/Earnings
GGNDF
PHIA
SOON
Financial Strength
|
Metric
|
GGNDF
|
PHIA
|
SOON
|
|---|---|---|---|
Quick Ratio | 0.48 | 0.74 | 0.76 |
Current Ratio | 0.65 | 1.20 | 1.29 |
Interest Coverage | 1.86 | −0.87 | 29.18 |
Quick Ratio
GGNDF
PHIA
SOON
Profitability
|
Metric
|
GGNDF
|
PHIA
|
SOON
|
|---|---|---|---|
Return on Assets (Normalized) | 0.30% | 3.84% | 11.96% |
Return on Equity (Normalized) | 1.10% | 9.21% | 30.61% |
Return on Invested Capital (Normalized) | 1.28% | 6.73% | 22.85% |
Return on Assets
GGNDF
PHIA
SOON
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lrhgbdxl | Hhstbbf | $185.4 Bil | |
SYK
| Stryker Corp | Qfpvzgbhc | Dhjd | $127.7 Bil | |
BSX
| Boston Scientific Corp | Pdxmyjxv | Zzlpkf | $107.6 Bil | |
MDT
| Medtronic PLC | Jjsgpcn | Xmhbxh | $105.9 Bil | |
DXCM
| DexCom Inc | Nmbwkyqq | Ytql | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Mbybpnlss | Dpnnns | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ghrkcwcvj | Sct | $24.6 Bil | |
ALGN
| Align Technology Inc | Dxvxyjp | Dgpdwdb | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Jllvcrjl | Vhkbkk | $18.7 Bil | |
PODD
| Insulet Corp | Mxrkdvgt | Kmqgmvl | $11.6 Bil |